River Rock Ventures & Others invest in Health-Tech Platform Remedo

Mumbai-based health-tech startup Remedo raises Pre-Series A round of funding from River Rock Ventures. The round also saw participation from Inflection Point Ventures, Angel List, Mohit Satyanand, Mitesh Daga (TPG Capital) and Aditya Vij (Kedara Capital). Remedo will use the fund to expand to other specialities like Cardiovascular, Neuro and Respirators.

Dr. Ruchir Mehra, Co-Founder, Remedo, says, “Remedo is an integrated care provider that uses various touch points between doctors and patients to manage chronic conditions, providing tools to adjust to the new reality of patient doctor moving online. Because of COVID outbreak, patients are unable to meet their doctors in person as it is not advisable to visit hospitals if one is not a Corona affected case. As a result, we have seen a clear acceptance among the stakeholders to take the telemedicine route. Our business has witnessed 17 percent growth in follow up visits for the doctors on the platform.”

Remedo is an integrated care provider that uses various touch points between doctors and patients to manage chronic conditions, providing tools to adjust to the new reality of patient doctor moving online

Remedo was co-founded by three experts – Dr. Ruchir, Harsh Bansal and Richeek Arya in 2017 as a telemedicine platform connecting over a lakh patients with doctors present on its platform. It offers customized care plans, including consultation, follow-up visit reminders, tests, medicine reminders and detailed answers to patients’ queries. Its smart health assistant ‘Disha’ delivers specialized wellness programs to patients as per their medical conditions.

Speaking about the investment, Shyam Anjaria, Investor, Inflection Point Ventures, says, “Remedo is tapping into a unique and highly scalable B2B Health-tech market in India, which is currently underserved. The innovative business model that Remedo brings the doctors and patients together on a platform is a key differentiator. With this backdrop coupled with IPV’s stage wise due diligence process, gave Remedo credibility and confidence for me to invest in the startup.” Angel platform Inflection Point Ventures’ investment in Remedo is its sixth investment in two months.